My colleague Vikas Dandekar of Pharmasianews reports on a potentially pathbreaking event. Swiss drug maker Roche has struck a manufacturing deal with Pune's Emcure to produce some portion of its blockbuster biologic Herceptin for breast cancer and Pegasys for hepatitis B and C in India for India. Of course, it doesn't look as if Emcure … Continue reading Roche’s Emcure deal – thumbs up for market economics?
Apothecurry 